BACKGROUND: β-Synuclein is an emerging synaptic blood biomarker for Alzheimer ́s disease (AD) and correlates with cognitive impairment, brain atrophy and amyloid/tau pathology. The gene discussed is SNCB; the disease is early-onset autosomal dominant Alzheimer disease.